Skip to main content
. 2015 Feb 15;2015:209569. doi: 10.1155/2015/209569

Table 2.

Summary of TAVI patient population characteristics at baseline in current studies.

Parameter Orvin et al., 2014 [8] Ghanem et al., 2013 [6] Kahlert et al., 2012 [9] Knipp et al., 2013 [10] Rodés-Cabau et al., 2011 [11] Kahlert et al., 2010 [12]
n 36 111 83 27 60 22 (ES) 10 (MCV)

Demographics
Age, mean ± SD 82.2 ± 4.2 80 ± 6 80.6 (79.3–81.8) 82.2 ± 4.7 83 ± 7 78.3 (76.4–80.2) 83.8 (79.2–88.4)
Male gender, % (n) 52.8 (19) 54 (60) 57.8% (35) 74.1 (20) 50 (30) 36 (14) 60 (4)

Risk scores
Logistic EuroSCORE, mean ± SD 14.9 ± 11.4 24.3 ± 14.7 20.7 (17.8–23.5) 36.4 ± 13.2 18.9 ± 12.8 22.8 (16.5–29.2) 17.9 (12.0–23.7)
Society of Thoracic Surgeons Score 7.4 ± 4.1 8.5 ± 5.4 6.7 (5.7–7.7) 7.7 ± 4.6

Cognitive status
Mini-mental status exam, mean ± SD 25.9 ± 3.3 25.4 ± 3.4 27.9 (27.5–28.3) 28 (17–30) 28.9 (28.2–29.6) 28.1 (26.7–29.5)
Mild cognitive impairment, % (n) 27 (30)

Comorbidities
Coronary artery disease, % (n) 63 (71) 55.4 (46) 55.5 (15) 73 (44) 64 (14) 50 (5)
Renal dysfunction, % (n) 30.5 (11) 16.9 (14) 88 (53)a 32 (7) 10 (1)

Cardiovascular risk factors
Obesity, % (n) 50.6 (42) 88 (53) 41 (9) 0 (0)
Smoking, % (n) 18 (20) 21.7 (18) 29.6 (8) 2 (1) 23 (5) 20 (2)
Diabetes, % (n) 30.5 (11) 31 (35) 30.1 (25) 29.6 (8) 25 (15) 27 (6) 40 (4)
Hypertension, % (n) 88.9 (32) 98 (109) 97.6 (81) 100 (27) 75 (45) 95 (21) 90 (9)
Dyslipidemia, % (n) 83.3 (30) 81 (90) 72.3 (60) 74.1 (20) 73 (44) 86 (19) 50 (5)

n = number, TAVI = transcatheter aortic valve implantation, SD = standard deviation, ES = Edwards-SAPIEN, MCV = Medtronic CoreValve.

aRenal dysfunction indicated by estimated glomerular filtration rate <60 mL/min.